Skip to main content
# Title Department Research Member Research Year
121 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2021
122 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Hossam El-Din / Mostafa Kamel Mohamed 2021
123 Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2021
124 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Duaa Abdel-Samia Mohamed Ali 2021
125 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
126 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
127 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2021
128 Laparoscopic versus Open Complete Mesocolic Excision for Right Colon Cancer Department of Pathology Dr. Marwa Tammam Ameen Hammam 2021
129 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Ali Zedan Tohamy mohammed 2021
130 The role of quantitative computed tomography perfusion in the assessment of colorectal thickening Department of Radiology Marwa Ali Mohammed Abdel fattah 2021